No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 1hnvB, 1.0000, 0.00, 1.000, 427, 427, STRUCTURE OF HIV-1 RT(SLASH)TIBO R 86183 COMPLEX REVEALS SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE INHIBITORS
2, 1uwbB, 0.9957, 0.49, 0.998, 427, 427, TYR 181 CYS HIV-1 RT/8-CL TIBO
3, 1tvrB, 0.9894, 0.78, 1.000, 427, 427, HIV-1 RT/9-CL TIBO
4, 2b6aB, 0.9850, 0.89, 0.988, 427, 426, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THR-50
5, 2banB, 0.9817, 1.08, 1.000, 427, 427, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R157208
6, 1hniB, 0.9800, 1.14, 0.981, 427, 426, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN A COMPLEX WITH THE NONNUCLEOSIDE INHIBITOR ALPHA-APA R 95845 AT 2.8 ANGSTROMS RESOLUTION
7, 2b5jB, 0.9798, 1.14, 1.000, 427, 427, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165481
8, 1s6qB, 0.9790, 1.17, 1.000, 427, 427, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R147681
9, 1s6pB, 0.9790, 1.15, 1.000, 427, 427, CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R100943
10, 1s9eB, 0.9780, 1.19, 1.000, 427, 427, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R129385
11, 1suqB, 0.9771, 1.30, 1.000, 427, 427, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R185545
12, 1s9gB, 0.9757, 1.12, 1.000, 425, 425, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R120394.
13, 4h4mB, 0.9752, 1.28, 0.995, 428, 427, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-CHLORO-5-(4-CHLORO-2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)- YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494) A NON-NUCLEOSIDE INHIBITOR
14, 4h4oB, 0.9746, 1.30, 0.995, 428, 427, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH (E)-3-(3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)- 4- FLUOROPHENOXY)-5-FLUOROPHENYL)ACRYLONITRILE (JLJ506) A NON- NUCLEOSIDE INHIBITOR
15, 4o44B, 0.9715, 1.40, 1.000, 427, 427, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4- ((4-(MESITYLAMINO)-6-(3-MORPHOLINOPROPOXY)-135-TRIAZIN-2-YL)AMINO) BENZONITRILE (JLJ529) A NON-NUCLEOSIDE INHIBITOR
16, 1bqnB, 0.9710, 1.55, 0.979, 430, 426, TYR 188 LEU HIV-1 RT/HBY 097
17, 1bqmB, 0.9706, 1.57, 0.986, 430, 426, HIV-1 RT/HBY 097
18, 1hpzB, 0.9701, 1.68, 0.998, 430, 427, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
19, 1hquB, 0.9698, 1.41, 0.998, 430, 425, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
20, 5c42B, 0.9659, 1.27, 0.995, 424, 423, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K101P) VARIANT IN COMPLEX WITH 8-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL) ETHOXY)PHENOXY)INDOLIZINE-2-CARBONITRILE (JLJ555) A NON-NUCLEOSIDE INHIBITOR
21, 1sv5B, 0.9642, 1.48, 0.998, 427, 424, CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165335
22, 4lslB, 0.9536, 1.18, 0.983, 417, 416, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-(4-CHLORO-2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)PHENYL)ACRYLONITRILE (JLJ476) A NON-NUCLEOSIDE INHIBITOR
23, 2be2B, 0.9524, 1.60, 0.976, 426, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH R221239
24, 2i5jB, 0.9517, 1.41, 0.995, 420, 418, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH DHBNH AN RNASE H INHIBITOR
25, 4rw8B, 0.9511, 1.19, 0.990, 415, 415, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-CHLORO-5-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)PHENYL)ACRYLONITRILE (JLJ532) A NON-NUCLEOSIDE INHIBITOR 
26, 1ikxB, 0.9505, 2.05, 0.960, 427, 426, K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR PNU142721
27, 4lsnB, 0.9479, 1.27, 0.986, 416, 415, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-BROMO-5-(4-CHLORO-2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)- YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ518) A NON-NUCLEOSIDE INHIBITOR
28, 2ic3B, 0.9472, 2.07, 0.976, 427, 424, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH NONNUCLEOSIDE INHIBITOR HBY 097
29, 4mfbB, 0.9424, 1.27, 0.988, 413, 412, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 8-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY) INDOLIZINE-2-CARBONITRILE (JLJ555) A NON-NUCLEOSIDE INHIBITOR
30, 5hbmB, 0.9414, 1.27, 0.973, 413, 412, CRYSTAL STRUCTURE OF A DIHYDROXYCOUMARIN RNASE H ACTIVE-SITE INHIBITOR IN COMPLEX WITH HIV-1 REVERSE TRANSCRIPTASE
31, 1tv6B, 0.9413, 1.13, 0.993, 411, 410, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94707
32, 5tw3B, 0.9380, 1.07, 0.985, 409, 408, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)-4-FLUOROPHENOXY)- 7-FLUORO-2-NAPHTHONITRILE (JLJ636) A NON-NUCLEOSIDE INHIBITOR
33, 3kleJ, 0.9376, 1.71, 0.971, 419, 417, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
34, 3kleN, 0.9365, 1.72, 0.969, 419, 417, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
35, 2ze2B, 0.9363, 1.68, 0.961, 416, 414, CRYSTAL STRUCTURE OF L100I/K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE) A NON-NUCLEOSIDE RT INHIBITOR
36, 5tepB, 0.9344, 1.04, 0.985, 407, 406, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 7-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-2- NAPHTHONITRILE (JLJ649) A NON-NUCLEOSIDE INHIBITOR
37, 4o4gB, 0.9331, 1.65, 0.959, 428, 414, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4- ((4-(MESITYLAMINO)-135-TRIAZIN-2-YL)AMINO)BENZONITRILE (JLJ527) A NON-NUCLEOSIDE INHIBITOR
38, 2jleB, 0.9330, 1.50, 0.976, 415, 413, NOVEL INDAZOLE NNRTIS CREATED USING MOLECULAR TEMPLATE HYBRIDIZATION BASED ON CRYSTALLOGRAPHIC OVERLAYS
39, 3kliB, 0.9323, 2.11, 0.958, 427, 424, CRYSTAL STRUCTURE OF UNLIGANDED AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE
40, 4q0bD, 0.9320, 1.46, 0.983, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GAP- RNA/DNA AND NEVIRAPINE
41, 4pwdD, 0.9318, 1.46, 0.983, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BULGE-RNA/DNA AND NEVIRAPINE
42, 3klhB, 0.9318, 2.20, 0.993, 428, 427, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
43, 3kleB, 0.9318, 1.82, 0.969, 425, 417, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
44, 3kleF, 0.9315, 1.84, 0.969, 419, 417, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
45, 3v81D, 0.9306, 1.49, 0.983, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND THE NONNUCLEOSIDE INHIBITOR NEVIRAPINE
46, 1n5yB, 0.9304, 2.23, 0.995, 429, 427, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST- TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
47, 4puoD, 0.9302, 1.50, 0.983, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND NEVIRAPINE
48, 1t03B, 0.9301, 2.23, 0.995, 429, 427, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIR TERMINATED TEMPLATE-PRIMER (COMPLEX P)
49, 1n6qB, 0.9299, 2.23, 0.995, 429, 427, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE- TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
50, 4dg1B, 0.9298, 1.94, 0.971, 418, 416, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH POLYMORPHISM MUTATION K172A AND K173A
51, 3v81B, 0.9297, 1.52, 0.983, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND THE NONNUCLEOSIDE INHIBITOR NEVIRAPINE
52, 1rtjB, 0.9296, 1.58, 0.961, 426, 412, MECHANISM OF INHIBITION OF HIV-1 REVERSE TRANSCRIPTASE BY NON-NUCLEOSIDE INHIBITORS
53, 3is9B, 0.9294, 1.90, 0.986, 416, 415, CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE ALKENYLDIARYLMETHANE (ADAM) NON-NUCLEOSIDE RT INHIBITOR DIMETHYL 33 -(6-METHOXY-6-OXOHEX-1-ENE-11- DIYL)BIS(5-CYANO-6-METHOXYBENZOATE).
54, 2yngB, 0.9294, 1.60, 0.973, 411, 410, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK560
55, 4puoB, 0.9291, 1.53, 0.983, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND NEVIRAPINE
56, 1r0aB, 0.9289, 2.20, 0.965, 429, 426, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLY TETHERED TO DNA TEMPLATE-PRIMER SOLVED TO 2.8 ANGSTROMS
57, 2yknB, 0.9288, 1.53, 0.980, 410, 410, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A DIFLUOROMETHYLBENZOXAZOLE (DFMB) PYRIMIDINE THIOETHER DERIVATIVE A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
58, 1rtdB, 0.9284, 1.60, 0.978, 414, 412, STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE
59, 4q0bB, 0.9280, 1.56, 0.983, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GAP- RNA/DNA AND NEVIRAPINE
60, 4pwdB, 0.9278, 1.56, 0.983, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BULGE-RNA/DNA AND NEVIRAPINE
61, 2wonB, 0.9278, 1.47, 0.968, 412, 410, CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (WILD-TYPE).
62, 3irxB, 0.9277, 1.92, 0.983, 416, 415, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE NON-NUCLEOSIDE RT INHIBITOR (E)-S-METHYL 5-(1-(37-DIMETHYL-2-OXO-23-DIHYDROBENZO[D]OXAZOL-5-YL)-5- (5-METHYL-134-OXADIAZOL-2-YL)PENT-1-ENYL)-2-METHOXY-3- METHYLBENZOTHIOATE.
63, 2womB, 0.9277, 1.47, 0.966, 412, 410, CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (K103N).
64, 6aocB, 0.9273, 1.84, 0.962, 425, 416, CRYSTAL STRUCTURE OF AN N-HYDROXYTHIENOPYRIMIDINE-2;4-DIONE RNASE H ACTIVE SITE INHIBITOR WITH MULTIPLE BINDING MODES TO HIV REVERSE TRANSCRIPTASE 
65, 1rthB, 0.9258, 1.51, 0.966, 420, 409, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
66, 1vruB, 0.9256, 1.47, 0.961, 410, 408, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
67, 6dugB, 0.9255, 1.66, 0.985, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE K101P MUTANT IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
68, 6dufB, 0.9254, 1.69, 0.981, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE V106A/F227L MUTANT IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
69, 6c0rB, 0.9254, 1.70, 0.985, 412, 411, CRYSTAL STRUCTURE OF HIV-1 K103N/Y181C MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
70, 6c0pB, 0.9252, 1.61, 0.968, 412, 410, CRYSTAL STRUCTURE OF HIV-1 E138K MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
71, 6c0oB, 0.9252, 1.70, 0.985, 412, 411, CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
72, 3bgrB, 0.9250, 1.62, 0.968, 412, 410, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE) A NON-NUCLEOSIDE RT INHIBITOR
73, 5c24B, 0.9249, 1.62, 0.968, 412, 410, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 7- ((4-((4-CYANOPHENYL)AMINO)-135-TRIAZIN-2-YL)AMINO)-68- DIMETHYLINDOLIZINE-2-CARBONITRILE (JLJ605) A NON-NUCLEOSIDE INHIBITOR
74, 4kkoB, 0.9249, 1.62, 0.961, 412, 410, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4- ((4-METHOXY-6-(2-MORPHOLINOETHOXY)-135-TRIAZIN-2-YL)AMINO)-2-((3- METHYLBUT-2-EN-1-YL)OXY)BENZONITRILE (JLJ513) A NON-NUCLEOSIDE INHIBITOR
75, 4i2qB, 0.9249, 1.72, 0.966, 416, 412, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RILPIVIRINE (TMC278) ANALOGUE
76, 1t05B, 0.9249, 1.67, 0.981, 414, 412, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE-PRIMER WITH TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMING NUCLEOTIDE SUBSTRATE
77, 4ig0B, 0.9248, 1.72, 0.959, 416, 412, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE 507 SITE
78, 4i2pB, 0.9248, 1.61, 0.961, 412, 410, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RILPIVIRINE (TMC278) BASED ANALOGUE
79, 1dttB, 0.9248, 1.39, 0.966, 412, 407, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT- 2 (PETT130A94)
80, 3ithB, 0.9247, 1.75, 0.973, 415, 414, CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
81, 1j5oB, 0.9247, 2.31, 0.972, 430, 426, CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE- PRIMER
82, 6c0kB, 0.9246, 1.71, 0.985, 412, 411, CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR K-5A2 
83, 1revB, 0.9246, 1.73, 0.961, 412, 410, HIV-1 REVERSE TRANSCRIPTASE
84, 6c0jB, 0.9245, 1.82, 0.981, 414, 413, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NON- NUCLEOSIDE INHIBITOR K-5A2 
85, 6cgfB, 0.9244, 1.82, 0.981, 414, 413, CRYSTAL STRUCTURE OF HIV-1 Y188L MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR K-5A2 
86, 3klfF, 0.9244, 1.68, 0.978, 413, 412, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
87, 3klfB, 0.9243, 1.68, 0.978, 413, 412, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
88, 6duhB, 0.9242, 1.71, 0.985, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE Y181I MUTANT IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
89, 5cyqB, 0.9242, 1.71, 0.966, 415, 412, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 4-BROMOPYRAZOLE
90, 6c0lB, 0.9241, 1.83, 0.978, 414, 413, CRYSTAL STRUCTURE OF HIV-1 E138K MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR K-5A2 
91, 1rtdD, 0.9241, 1.69, 0.978, 414, 412, STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE
92, 6c0nB, 0.9240, 1.72, 0.985, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NON- NUCLEOSIDE INHIBITOR 25A 
93, 3jsmB, 0.9240, 1.70, 0.983, 413, 412, K65R MUTANT HIV-1 REVERSE TRANSCRIPTASE CROSS-LINKED TO DS-DNA AND COMPLEXED WITH TENOFOVIR-DIPHOSPHATE AS THE INCOMING NUCLEOTIDE SUBSTRATE
94, 4b3oB, 0.9239, 1.37, 0.970, 410, 406, STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT CONFORMATION AND SUBSTRATE INTERFACE
95, 6eliB, 0.9236, 1.73, 0.966, 416, 412, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH RILPIVIRINE AND AN RNASE H INHIBITOR XZ462 
96, 4ig3B, 0.9236, 1.74, 0.966, 416, 412, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT NEAR KNUCKLES SITE
97, 2ynhB, 0.9236, 1.37, 0.973, 406, 405, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK500
98, 3klgB, 0.9235, 1.67, 0.973, 413, 412, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
99, 3ithD, 0.9234, 1.85, 0.983, 415, 415, CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
100, 2zd1B, 0.9230, 1.66, 0.968, 412, 410, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE) A NON-NUCLEOSIDE RT INHIBITOR
101, 3v4iD, 0.9229, 1.66, 0.985, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND AZTTP
102, 2ynfB, 0.9228, 1.39, 0.970, 406, 405, HIV-1 REVERSE TRANSCRIPTASE Y188L MUTANT IN COMPLEX WITH INHIBITOR GSK560
103, 2ykmB, 0.9228, 1.66, 0.983, 410, 410, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A DIFLUOROMETHYLBENZOXAZOLE (DFMB) PYRIMIDINE THIOETHER DERIVATIVE A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
104, 4g1qB, 0.9227, 1.75, 0.966, 416, 412, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH RILPIVIRINE (TMC278 EDURANT) A NON-NUCLEOSIDE RT-INHIBITING DRUG
105, 3klgF, 0.9227, 1.69, 0.973, 413, 412, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
106, 2rf2B, 0.9226, 1.25, 0.983, 405, 404, HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 7E (NNRTI)
107, 5txpB, 0.9223, 1.68, 0.981, 412, 411, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
108, 3dlkB, 0.9222, 1.52, 0.971, 409, 408, CRYSTAL STRUCTURE OF AN ENGINEERED FORM OF THE HIV-1 REVERSE TRANSCRIPTASE RT69A
109, 4r5pB, 0.9221, 1.69, 0.981, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND A NUCLEOSIDE TRIPHOSPHATE MIMIC ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR
110, 3v6dD, 0.9221, 1.68, 0.988, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) CROSS-LINKED WITH AZT-TERMINATED DNA
111, 3v6dB, 0.9220, 1.69, 0.981, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) CROSS-LINKED WITH AZT-TERMINATED DNA
112, 3qo9B, 0.9219, 1.81, 0.966, 412, 410, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TSAO-T A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
113, 4iclB, 0.9218, 1.68, 0.971, 412, 410, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE INCOMING DNTP BINDING SITE
114, 5txnB, 0.9216, 1.70, 0.981, 412, 411, STRUCTURE OF Q151M MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
115, 4ifyB, 0.9216, 1.67, 0.956, 412, 410, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE KNUCKLES SITE
116, 4r5pD, 0.9215, 1.69, 0.983, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND A NUCLEOSIDE TRIPHOSPHATE MIMIC ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR
117, 1ikwB, 0.9215, 1.34, 0.980, 405, 405, WILD TYPE HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFAVIRENZ
118, 1c1bB, 0.9215, 1.41, 0.966, 415, 406, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GCA- 186
119, 5txoB, 0.9213, 1.70, 0.981, 412, 411, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
120, 5hroD, 0.9213, 1.69, 0.981, 412, 411, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND AN ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR (ALPHA-CNP)
121, 5txoD, 0.9212, 1.69, 0.981, 412, 411, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
122, 3klfJ, 0.9211, 1.79, 0.978, 413, 412, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
123, 4ifvB, 0.9210, 1.69, 0.963, 412, 410, DETECTING ALLOSTERIC SITES OF HIV-1 REVERSE TRANSCRIPTASE BY X-RAY CRYSTALLOGRAPHIC FRAGMENT SCREENING
124, 4idkB, 0.9210, 1.68, 0.971, 412, 410, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE 428 SITE
125, 2hmiB, 0.9209, 2.35, 0.955, 430, 425, HIV-1 REVERSE TRANSCRIPTASE/FRAGMENT OF FAB 28/DNA COMPLEX
126, 5txpD, 0.9208, 1.70, 0.985, 412, 411, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
127, 5i42D, 0.9207, 1.70, 0.981, 412, 411, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AZTTP AND CA(2+) ION
128, 5txnD, 0.9206, 1.70, 0.985, 412, 411, STRUCTURE OF Q151M MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
129, 3v4iB, 0.9206, 1.72, 0.981, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND AZTTP
130, 3jytB, 0.9206, 1.76, 0.983, 413, 412, K65R MUTANT HIV-1 REVERSE TRANSCRIPTASE CROSS-LINKED TO DS- DNA AND COMPLEXED WITH DATP AS THE INCOMING NUCLEOTIDE SUBSTRATE
131, 4id5B, 0.9203, 1.71, 0.971, 412, 410, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE RNASE H PRIMER GRIP SITE
132, 1qe1B, 0.9203, 1.85, 0.961, 415, 414, CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE TRANSCRIPTASE
133, 5txlD, 0.9201, 1.71, 0.978, 412, 411, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
134, 5i42B, 0.9200, 1.72, 0.981, 412, 411, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AZTTP AND CA(2+) ION
135, 4pquB, 0.9199, 1.73, 0.983, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND DATP
136, 3klfN, 0.9199, 1.82, 0.978, 413, 412, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
137, 4b3qB, 0.9198, 1.46, 0.970, 410, 406, STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT CONFORMATION AND SUBSTRATE INTERFACE
138, 1ikyB, 0.9198, 1.38, 0.978, 405, 405, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC194
139, 5txmD, 0.9196, 1.72, 0.978, 412, 411, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
140, 4kfbB, 0.9192, 1.72, 0.963, 412, 410, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT NNRTI ADJACENT SITE
141, 3qlhB, 0.9192, 1.53, 0.973, 407, 406, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH MANICOL AT THE RNASE H ACTIVE SITE AND TMC278 (RILPIVIRINE) AT THE NNRTI BINDING POCKET
142, 3isnD, 0.9191, 1.85, 0.964, 415, 414, CRYSTAL STRUCTURE OF HIV-1 RT BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
143, 3i0sB, 0.9190, 1.34, 0.978, 405, 404, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 7
144, 1ikvB, 0.9190, 1.34, 0.985, 404, 404, K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFIVARENZ
145, 5txmB, 0.9189, 1.71, 0.978, 411, 410, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
146, 5txlB, 0.9185, 1.71, 0.978, 411, 410, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
147, 2yniB, 0.9184, 1.39, 0.973, 404, 403, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK952
148, 5hroB, 0.9183, 1.76, 0.981, 412, 411, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND AN ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR (ALPHA-CNP)
149, 1hysB, 0.9178, 2.37, 0.974, 425, 424, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A POLYPURINE TRACT RNA:DNA
150, 3i0rB, 0.9177, 1.36, 0.980, 405, 404, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 3
151, 3drrB, 0.9176, 1.32, 0.980, 404, 403, HIV REVERSE TRANSCRIPTASE Y181C MUTANT IN COMPLEX WITH INHIBITOR R8E
152, 3c6uB, 0.9175, 1.32, 0.983, 404, 403, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 22
153, 3ig1B, 0.9171, 1.69, 0.968, 409, 408, HIV-1 REVERSE TRANSCRIPTASE WITH THE INHIBITOR BETA- THUJAPLICINOL BOUND AT THE RNASE H ACTIVE SITE
154, 3c6tB, 0.9171, 1.32, 0.983, 404, 403, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 14
155, 1rtiB, 0.9169, 1.36, 0.965, 413, 403, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
156, 5hlfB, 0.9168, 2.00, 0.988, 416, 414, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER AND AN ALPHA-CARBOXYPHOSPHONATE INHIBITOR
157, 5vqsB, 0.9165, 1.30, 0.975, 403, 402, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N-(6- CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-4-METHYLNAPHTHALEN-1-YL)ACRYLAMIDE (JLJ685) A NON- NUCLEOSIDE INHIBITOR
158, 3drpB, 0.9165, 1.34, 0.983, 404, 403, HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR R8E
159, 5i3uB, 0.9163, 2.00, 0.988, 416, 414, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE N-SITE COMPLEX; CATALYTIC INCORPORATION OF AZTMP TO A DNA APTAMER IN CRYSTAL
160, 5d3gD, 0.9163, 1.76, 0.966, 410, 409, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE BOUND TO A NOVEL 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER
161, 4we1B, 0.9161, 1.25, 0.980, 402, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-2- NAPHTHONITRILE (JLJ600)
162, 5hp1B, 0.9160, 2.01, 0.988, 416, 414, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND FOSCARNET A PYROPHOSPHATE ANALOG
163, 4kv8B, 0.9157, 1.60, 0.980, 407, 406, CRYSTAL STRUCTURE OF HIV RT IN COMPLEX WITH BILR0355BS
164, 1lw2B, 0.9155, 1.54, 0.960, 406, 404, CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 1051U91
165, 5c25B, 0.9153, 1.54, 0.978, 406, 405, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 6- ((4-((4-CYANOPHENYL)AMINO)-135-TRIAZIN-2-YL)AMINO)-57-DIMETHYL-2- NAPHTHONITRILE (JLJ639) A NON-NUCLEOSIDE INHIBITOR
166, 4ko0B, 0.9153, 1.67, 0.971, 410, 407, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH AN ANILINYLPYRIMIDINE DERIVATIVE (JLJ-135)
167, 1dloB, 0.9152, 1.90, 0.947, 415, 413, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
168, 5i3uD, 0.9151, 1.80, 0.966, 410, 409, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE N-SITE COMPLEX; CATALYTIC INCORPORATION OF AZTMP TO A DNA APTAMER IN CRYSTAL
169, 3drsB, 0.9149, 1.43, 0.980, 405, 404, HIV REVERSE TRANSCRIPTASE K103N MUTANT IN COMPLEX WITH INHIBITOR R8D
170, 1s1tB, 0.9149, 1.42, 0.968, 416, 403, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
171, 5hp1D, 0.9148, 1.81, 0.968, 410, 409, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND FOSCARNET A PYROPHOSPHATE ANALOG
172, 1jlqB, 0.9148, 1.42, 0.970, 405, 403, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 739W94
173, 5cymB, 0.9144, 1.61, 0.975, 408, 406, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 4-IODOPYRAZOLE
174, 5d3gB, 0.9141, 1.99, 0.978, 415, 413, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE BOUND TO A NOVEL 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER
175, 1c1cB, 0.9141, 1.45, 0.970, 416, 403, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK- 6123
176, 1fkoB, 0.9139, 1.40, 0.975, 403, 402, CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ)
177, 5hlfD, 0.9138, 1.83, 0.966, 410, 409, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER AND AN ALPHA-CARBOXYPHOSPHONATE INHIBITOR
178, 3megB, 0.9136, 1.34, 0.975, 404, 402, HIV-1 K103N REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC278
179, 1fk9B, 0.9133, 1.43, 0.960, 403, 402, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP- 266(EFAVIRENZ)
180, 4i7fB, 0.9132, 1.43, 0.975, 405, 403, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A PHOSPHONATE ANALOG OF NEVIRAPINE
181, 1s1wB, 0.9132, 1.52, 0.963, 404, 403, CRYSTAL STRUCTURE OF V106A MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
182, 4rw4B, 0.9128, 1.52, 0.980, 405, 403, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103NY181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(4-CHLORO-2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494) A NON-NUCLEOSIDE INHIBITOR
183, 1lwcB, 0.9124, 1.41, 0.973, 402, 401, CRYSTAL STRUCTURE OF M184V MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
184, 6aocD, 0.9120, 2.08, 0.981, 416, 414, CRYSTAL STRUCTURE OF AN N-HYDROXYTHIENOPYRIMIDINE-2;4-DIONE RNASE H ACTIVE SITE INHIBITOR WITH MULTIPLE BINDING MODES TO HIV REVERSE TRANSCRIPTASE 
185, 5tuqB, 0.9120, 1.58, 0.975, 405, 404, CRYSTAL STRUCTURE OF A 6-CYCLOHEXYLMETHYL-3-HYDROXYPYRIMIDINE-24- DIONE INHIBITOR IN COMPLEX WITH HIV REVERSE TRANSCRIPTASE
186, 3lamB, 0.9118, 1.33, 0.980, 403, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-PROPYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
187, 1jlbB, 0.9118, 1.38, 0.970, 405, 401, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
188, 1vrtB, 0.9114, 1.35, 0.975, 401, 400, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
189, 2iajB, 0.9112, 1.92, 0.922, 415, 412, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH ATP
190, 4rw7B, 0.9110, 1.55, 0.978, 405, 403, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ532) A NON-NUCLEOSIDE INHIBITOR
191, 4rw9B, 0.9109, 1.56, 0.978, 405, 403, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ532) A NON- NUCLEOSIDE INHIBITOR
192, 1tkzB, 0.9108, 1.45, 0.968, 401, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW429576
193, 1rt5B, 0.9108, 1.41, 0.973, 406, 401, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC10
194, 6bsiB, 0.9107, 1.24, 0.970, 406, 399, STRUCTURE OF HIV-1 RT COMPLEXED WITH AN RNA/DNA HYBRID CONTAINING THE POLYPURINE-TRACT SEQUENCE
195, 3lakB, 0.9105, 1.37, 0.980, 403, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-HETEROCYCLE PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
196, 1tl3B, 0.9104, 1.46, 0.968, 401, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW450557
197, 1rt7B, 0.9104, 1.48, 0.973, 415, 402, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC84
198, 3lanB, 0.9102, 1.38, 0.980, 403, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-BUTYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
199, 2vg5B, 0.9102, 1.34, 0.972, 401, 400, CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
200, 4pquD, 0.9101, 2.00, 0.988, 413, 412, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND DATP
201, 4rw6B, 0.9100, 1.58, 0.978, 405, 403, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(4-CHLORO-2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494) A NON-NUCLEOSIDE INHIBITOR
202, 4b3pB, 0.9097, 1.38, 0.970, 404, 400, STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT CONFORMATION AND SUBSTRATE INTERFACE
203, 1s1uB, 0.9095, 1.42, 0.962, 401, 400, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
204, 1rt1B, 0.9094, 1.50, 0.970, 415, 402, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH MKC-442
205, 1jleB, 0.9094, 1.44, 0.978, 408, 401, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE
206, 3tamB, 0.9093, 1.46, 0.980, 403, 402, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N MUTANT) IN COMPLEX WITH INHIBITOR M06
207, 3lp1B, 0.9093, 1.30, 0.977, 400, 399, HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
208, 5vquB, 0.9089, 1.42, 0.985, 401, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-2-FLUORO-N- METHYLACETAMIDE (JLJ683) A NON-NUCLEOSIDE INHIBITOR
209, 3kk2B, 0.9089, 1.91, 0.978, 414, 411, HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH DATP BOUND IN THE NUCLEOTIDE BINDING SITE
210, 5vqvB, 0.9088, 1.42, 0.985, 401, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N-METHYLACRYLAMIDE (JLJ684) A NON-NUCLEOSIDE INHIBITOR
211, 3lalB, 0.9088, 1.41, 0.980, 403, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-ETHYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
212, 5vqzB, 0.9085, 1.43, 0.985, 401, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N Y181C) VARIANT IN COMPLEX WITH 2-CHLORO-N-(6-CYANO-3-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N- METHYLACETAMIDE (JLJ686) A NON-NUCLEOSIDE INHIBITOR
213, 5vqyB, 0.9085, 1.43, 0.985, 401, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N- METHYLACRYLAMIDE (JLJ684) A NON-NUCLEOSIDE INHIBITOR
214, 1rt6B, 0.9085, 1.47, 0.970, 414, 401, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC38
215, 5vqxB, 0.9084, 1.43, 0.985, 401, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH 2-CHLORO-N-(6-CYANO-3-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N- METHYLACETAMIDE (JLJ686) A NON-NUCLEOSIDE INHIBITOR
216, 5vqwB, 0.9082, 1.43, 0.985, 401, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)ACRYLAMIDE (JLJ685) A NON-NUCLEOSIDE INHIBITOR
217, 3meeB, 0.9081, 1.31, 0.982, 401, 399, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC278
218, 5terB, 0.9080, 1.43, 0.985, 401, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5- CHLORO-7-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-8-METHYL-2-NAPHTHONITRILE (JLJ651) A NON-NUCLEOSIDE INHIBITOR
219, 2vg6B, 0.9080, 1.41, 0.970, 401, 400, CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
220, 2hnyB, 0.9080, 1.47, 0.962, 401, 400, CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
221, 3dyaB, 0.9078, 1.53, 0.970, 402, 401, HIV-1 RT WITH NON-NUCLEOSIDE INHIBITOR ANNULATED PYRAZOLE 1
222, 6bsgB, 0.9077, 1.28, 0.977, 404, 398, STRUCTURE OF HIV-1 RT COMPLEXED WITH RNA/DNA HYBRID IN AN RNA HYDROLYSIS-OFF MODE
223, 6bshB, 0.9076, 1.27, 0.977, 404, 398, STRUCTURE OF HIV-1 RT COMPLEXED WITH RNA/DNA HYBRID IN THE RNA HYDROLYSIS MODE
224, 1c0uB, 0.9076, 1.49, 0.973, 414, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+50.0934
225, 4zhrB, 0.9075, 1.83, 0.941, 409, 408, STRUCTURE OF HIV-1 RT Q151M MUTANT
226, 3ffiB, 0.9075, 1.60, 0.970, 403, 402, HIV-1 RT WITH PYRIDONE NON-NUCLEOSIDE INHIBITOR
227, 1dtqB, 0.9072, 1.55, 0.983, 402, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT- 1 (PETT131A94)
228, 5k14B, 0.9070, 1.34, 0.982, 401, 399, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A 26-DIFLUOROPHENYL DAPY ANALOG
229, 3qipB, 0.9069, 1.35, 0.980, 402, 399, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH AN RNASE H INHIBITOR AND NEVIRAPINE
230, 5vqtB, 0.9068, 1.41, 0.985, 400, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 2- CHLORO-N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL) ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N-METHYLACETAMIDE (JLJ686) A NON-NUCLEOSIDE INHIBITOR
231, 2oppB, 0.9068, 1.44, 0.962, 403, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
232, 1lw0B, 0.9068, 1.38, 0.972, 399, 398, CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
233, 5vqrB, 0.9067, 1.42, 0.985, 400, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N-(6- CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N-METHYLACRYLAMIDE (JLJ684) A NON- NUCLEOSIDE INHIBITOR
234, 5vqqB, 0.9064, 1.42, 0.985, 400, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N-(6- CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-2-FLUORO-N-METHYLACETAMIDE (JLJ683) A NON-NUCLEOSIDE INHIBITOR
235, 3dolB, 0.9064, 1.50, 0.968, 405, 401, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW695634.
236, 1tktB, 0.9064, 1.45, 0.970, 399, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW426318
237, 4ncgB, 0.9062, 1.36, 0.980, 402, 399, DISCOVERY OF DORAVIRINE AN ORALLY BIOAVAILABLE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR POTENT AGAINST A WIDE RANGE OF RESISTANT MUTANT HIV VIRUSES
238, 2opqB, 0.9061, 1.45, 0.965, 400, 399, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
239, 1eetB, 0.9061, 1.39, 0.987, 399, 399, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204
240, 5vz6B, 0.9060, 1.37, 0.980, 400, 399, HIV REVERSE TRANSCRIPTASE COMPLEXED WITH (E)-3-(PYRIMIDIN-2-YL)-N-(5- (5;6;7;8-TETRAHYDRONAPHTHALEN-2-YL)-1H-PYRAZOL-3-YL)ACRYLAMIDE 
241, 3m8pB, 0.9060, 1.50, 0.972, 401, 400, HIV-1 RT WITH NNRTI TMC-125
242, 3mecB, 0.9059, 1.37, 0.980, 401, 399, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC125
243, 2rkiB, 0.9054, 1.45, 0.977, 402, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A TRIAZOLE DERIVED NNRTI
244, 3medB, 0.9052, 1.39, 0.977, 401, 399, HIV-1 K103N REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC125
245, 1rt3B, 0.9051, 1.29, 0.967, 398, 397, AZT DRUG RESISTANT HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 1051U91
246, 2hnzB, 0.9050, 1.41, 0.965, 399, 398, CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2
247, 1klmB, 0.9048, 1.44, 0.967, 405, 399, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH BHAP U-90152
248, 1jlfB, 0.9042, 1.46, 0.975, 404, 399, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
249, 1fkpB, 0.9040, 1.35, 0.975, 408, 397, CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
250, 3t1aB, 0.9039, 1.42, 0.977, 400, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N MUTANT) IN COMPLEX WITH INHIBITOR M05
251, 3lp2B, 0.9039, 1.42, 0.977, 400, 399, HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
252, 3lp0B, 0.9039, 1.43, 0.977, 400, 399, HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
253, 1jlgB, 0.9038, 1.47, 0.972, 405, 399, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
254, 1rt4B, 0.9033, 1.42, 0.980, 404, 398, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC781
255, 3dokB, 0.9030, 1.42, 0.965, 402, 398, CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW678248.
256, 1lweB, 0.9029, 1.54, 0.967, 401, 400, CRYSTAL STRUCTURE OF M41L/T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMN) IN COMPLEX WITH NEVIRAPINE
257, 3kk1B, 0.9027, 1.95, 0.980, 412, 409, HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH NUCEOTIDE INHIBITOR GS- 9148-DIPHOSPHATE BOUND IN NUCLEOTIDE SITE
258, 1tl1B, 0.9027, 1.41, 0.962, 400, 397, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW451211
259, 3di6B, 0.9026, 1.45, 0.977, 400, 399, HIV-1 RT WITH PYRIDAZINONE NON-NUCLEOSIDE INHIBITOR
260, 1hqeB, 0.9024, 2.03, 0.963, 415, 409, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
261, 1jlcB, 0.9017, 1.40, 0.972, 402, 397, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2
262, 3dleB, 0.9015, 1.46, 0.980, 403, 398, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GF128590.
263, 6bsjB, 0.9009, 1.20, 0.977, 400, 394, STRUCTURE OF HIV-1 RT COMPLEXED WITH AN RNA/DNA HYBRID SEQUENCE NON- PREFERRED FOR RNA HYDROLYSIS
264, 3t19B, 0.9009, 1.50, 0.980, 400, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (WILD TYPE) IN COMPLEX WITH INHIBITOR M05
265, 1hvuK, 0.9009, 1.43, 0.935, 400, 398, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
266, 1hvuH, 0.9009, 1.43, 0.935, 400, 398, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
267, 1hvuE, 0.9009, 1.43, 0.935, 400, 398, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
268, 1hvuB, 0.9009, 1.43, 0.935, 400, 398, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
269, 1ep4B, 0.9009, 1.30, 0.972, 395, 395, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH S- 1153
270, 3nbpB, 0.9007, 1.60, 0.962, 400, 399, HIV-1 REVERSE TRANSCRIPTASE WITH AMINOPYRIMIDINE INHIBITOR 2
271, 5fdlB, 0.9005, 1.27, 0.965, 396, 395, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH IDX899
272, 3e01B, 0.9002, 1.67, 0.972, 401, 400, HIV-RT WITH NON-NUCLEOSIDE INHIBITOR ANNULATED PYRAZOLE 2
273, 1s1xB, 0.8992, 1.38, 0.962, 397, 396, CRYSTAL STRUCTURE OF V108I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
274, 5xn1B, 0.8988, 1.89, 0.956, 407, 406, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA:ENTECAVIR-TRIPHOSPHATE TERNARY COMPLEX
275, 2oprB, 0.8986, 1.43, 0.977, 400, 396, CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
276, 1jkhB, 0.8986, 1.48, 0.972, 398, 397, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ)
277, 5xn2B, 0.8985, 1.90, 0.956, 407, 406, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA:DGTP TERNARY COMPLEX
278, 1jlaB, 0.8980, 1.38, 0.975, 408, 395, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651
279, 2vg7B, 0.8979, 1.30, 0.980, 395, 394, CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
280, 2hndB, 0.8979, 1.24, 0.967, 394, 393, CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
281, 1tkxB, 0.8979, 1.45, 0.977, 404, 396, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW490745
282, 3kk3B, 0.8978, 1.80, 0.955, 407, 404, HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH GS-9148 TERMINATED PRIMER
283, 3m8qB, 0.8973, 1.57, 0.965, 398, 397, HIV-1 RT WITH AMINOPYRIMIDINE NNRTI
284, 5xn0B, 0.8971, 1.93, 0.958, 407, 406, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA BINARY COMPLEX
285, 2opsB, 0.8971, 1.46, 0.977, 409, 396, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
286, 3hvtB, 0.8969, 1.48, 0.937, 398, 396, STRUCTURAL BASIS OF ASYMMETRY IN THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE HETERODIMER
287, 1rt2B, 0.8964, 1.54, 0.972, 402, 397, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH TNK-651
288, 1s1vB, 0.8961, 1.42, 0.975, 404, 395, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651
289, 5j1eB, 0.8941, 1.94, 0.948, 405, 404, CRYSTAL STRUCTURE OF A HYDROXYPYRIDONE CARBOXYLIC ACID ACTIVE-SITE RNASE H INHIBITOR IN COMPLEX WITH HIV REVERSE TRANSCRIPTASE
290, 1lwfB, 0.8937, 1.45, 0.970, 395, 394, CRYSTAL STRUCTURE OF A MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMQ+M184V: M41L/D67N/K70R/M184V/T215Y) IN COMPLEX WITH NEVIRAPINE
291, 5j2nB, 0.8913, 1.87, 0.978, 405, 402, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA THAT HAS INCORPORATED EFDA-MP AT THE P-(POST-TRANSLOCATION) SITE AND DTMP AT THE N-(PRE- TRANSLOCATION) SITE
292, 5uv5B, 0.8908, 1.78, 0.952, 400, 399, CRYSTAL STRUCTURE OF A 2-HYDROXYISOQUINOLINE-13-DIONE RNASE H ACTIVE SITE INHIBITOR WITH MULTIPLE BINDING MODES TO HIV REVERSE TRANSCRIPTASE
293, 5xn1D, 0.8906, 2.07, 0.941, 407, 406, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA:ENTECAVIR-TRIPHOSPHATE TERNARY COMPLEX
294, 5xn2D, 0.8903, 2.08, 0.941, 407, 406, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA:DGTP TERNARY COMPLEX
295, 3dmjB, 0.8892, 1.38, 0.972, 401, 391, CRYSTAL STRUCTURE OF HIV-1 V106A AND Y181C MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
296, 5xn0D, 0.8888, 2.11, 0.936, 407, 406, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA BINARY COMPLEX
297, 3dm2B, 0.8869, 1.38, 0.977, 400, 390, CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
298, 3dlgB, 0.8868, 1.38, 0.979, 400, 390, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
299, 5j2pB, 0.8862, 1.85, 0.980, 400, 399, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA THAT HAS INCORPORATED EFDA-MP AT THE P-(POST-TRANSLOCATION) SITE AND A SECOND EFDA-MP AT THE N-(PRE-TRANSLOCATION) SITE
300, 1hmvH, 0.8858, 1.58, 0.975, 395, 394, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
301, 1hmvF, 0.8858, 1.58, 0.975, 395, 394, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
302, 1hmvD, 0.8858, 1.58, 0.975, 395, 394, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
303, 1hmvB, 0.8858, 1.58, 0.975, 395, 394, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
304, 3kjvB, 0.8839, 1.74, 0.980, 400, 396, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA
305, 5j2qB, 0.8827, 1.82, 0.977, 400, 397, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA THAT HAS INCORPORATED A MISMATCHED EFDA-MP AT THE N-(PRE-TRANSLOCATION) SITE
306, 5uv5D, 0.8826, 1.63, 0.990, 393, 393, CRYSTAL STRUCTURE OF A 2-HYDROXYISOQUINOLINE-13-DIONE RNASE H ACTIVE SITE INHIBITOR WITH MULTIPLE BINDING MODES TO HIV REVERSE TRANSCRIPTASE
307, 5j1eD, 0.8812, 1.65, 0.987, 393, 393, CRYSTAL STRUCTURE OF A HYDROXYPYRIDONE CARBOXYLIC ACID ACTIVE-SITE RNASE H INHIBITOR IN COMPLEX WITH HIV REVERSE TRANSCRIPTASE
308, 5j2mB, 0.8793, 1.80, 0.980, 398, 395, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA AND EFDA-TRIPHOSPHATE A TRANSLOCATION-DEFECTIVE RT INHIBITOR
309, 6b19B, 0.8625, 2.23, 0.935, 399, 398, ARCHITECTURE OF HIV-1 REVERSE TRANSCRIPTASE INITIATION COMPLEX CORE 
310, 1mu2B, 0.8520, 2.46, 0.559, 402, 397, CRYSTAL STRUCTURE OF HIV-2 REVERSE TRANSCRIPTASE
311, 5ovnB, 0.8505, 2.61, 0.428, 405, 402, CRYSTAL STRUCURE OF FIV REVERSE TRANSCRIPTASE
312, 1c0tB, 0.8486, 1.33, 0.981, 373, 372, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+21.1326
313, 4kseB, 0.7373, 2.17, 0.943, 401, 332, CRYSTAL STRUCTURE OF A HIV P51 (219-230) DELETION MUTANT
314, 4ol8B, 0.6548, 5.14, 0.132, 447, 378, TY3 REVERSE TRANSCRIPTASE BOUND TO DNA/RNA
315, 4ol8F, 0.6322, 5.01, 0.122, 422, 362, TY3 REVERSE TRANSCRIPTASE BOUND TO DNA/RNA
